Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
1.
Pathol Res Pract ; 216(1): 152721, 2020 Jan.
Article in English | MEDLINE | ID: mdl-31759784

ABSTRACT

Time optimization and cost reduction without quality loss is fundamental for scientific production. The TMA technique allows large-scale analysis of paraffin-embedded and fixed tissues using non-decalcified bone marrow specimens. Cytoinclusion samples (n = 264) were selected from patients diagnosed with monoclonal gammopathy (n = 189) at Botucatu Medical School, São Paulo State University. Slides were cut from the TMA block and stained with H&E and immunohistochemical markers. Of the 276 fragments included in the receptor block, 45 core detachments were observed, thus 84% of the samples remained viable. The representative material allowed for adequate analysis of isolated cells, which showed nuclear, cytoplasmic and membrane staining. Thus, we verified that inclusion of bone marrow aspirate clot is a valid alternative for TMA histological and immunohistochemical analyses.


Subject(s)
Bone Marrow/pathology , Monoclonal Gammopathy of Undetermined Significance/pathology , Staining and Labeling , Biopsy/methods , Humans , Paraffin Embedding/methods , Tissue Array Analysis/methods , Tissue Fixation/methods
2.
Mod Pathol ; 26(9): 1183-96, 2013 Sep.
Article in English | MEDLINE | ID: mdl-23599146

ABSTRACT

Follicular lymphoma is clinically heterogenous, and therefore necessitates the identification of prognostic markers to stratify risk groups and optimize clinical management. It is relatively rare in patients younger than 40 years, and the clinicopathologic characteristics and biological behavior in this age group are poorly understood. In the current study, samples from a cohort of 200 patients between 19 and 40 years were evaluated retrospectively with respect to clinical, histologic, and genetic features. These were then correlated with clinical outcome. The median age at presentation was 35 years with a slight female prepoderance (56%). Most of the cases are presented with nodal disease (90%). Concomitant follicular lymphoma and diffuse large B-cell lymphoma were observed in 7 (4%) patients. Immunohistologic studies showed the expression of CD10 (91%), BCL6 (97%), BCL2 (95%), MUM1/IRF4 (12%), MDM2 (17%), and CD23 (25%). BCL2 rearrangement was present in 74%, and BCL6 in 20%. The estimated overall survival of patients was 13 years (mean). The presence of anemia, elevated lactose dehydrogenase, bone marrow involvement, and high-risk follicular lymphoma international prognostic index correlated with adverse overall survival. Our findings revealed that follicular lymphoma in young adults demonstrate similarities with that of older adults, including the frequency of presentation at various anatomic sites, grade, and adverse prognostic factors.


Subject(s)
Biomarkers, Tumor/analysis , Lymphoma, Follicular/diagnosis , Lymphoma, Large B-Cell, Diffuse/diagnosis , Adult , Age Factors , Biomarkers, Tumor/genetics , Cluster Analysis , Female , Humans , Immunohistochemistry , In Situ Hybridization, Fluorescence , Kaplan-Meier Estimate , Logistic Models , Lymph Nodes/chemistry , Lymph Nodes/pathology , Lymphoma, Follicular/chemistry , Lymphoma, Follicular/genetics , Lymphoma, Follicular/mortality , Lymphoma, Follicular/pathology , Lymphoma, Follicular/therapy , Lymphoma, Large B-Cell, Diffuse/chemistry , Lymphoma, Large B-Cell, Diffuse/genetics , Lymphoma, Large B-Cell, Diffuse/mortality , Lymphoma, Large B-Cell, Diffuse/pathology , Male , Neoplasm Grading , Neoplasm Staging , Odds Ratio , Predictive Value of Tests , Risk Factors , Time Factors , Treatment Outcome , Young Adult
3.
Mod Pathol ; 25(11): 1439-45, 2012 Nov.
Article in English | MEDLINE | ID: mdl-22743653

ABSTRACT

Diffuse large B-cell lymphoma can be subclassified into at least two molecular subgroups by gene expression profiling: germinal center B-cell like and activated B-cell like diffuse large B-cell lymphoma. Several immunohistological algorithms have been proposed as surrogates to gene expression profiling at the level of protein expression, but their reliability has been an issue of controversy. Furthermore, the proportion of misclassified cases of germinal center B-cell subgroup by immunohistochemistry, in all reported algorithms, is higher compared with germinal center B-cell cases defined by gene expression profiling. We analyzed 424 cases of nodal diffuse large B-cell lymphoma with the panel of markers included in the three previously described algorithms: Hans, Choi, and Tally. To test whether the sensitivity of detecting germinal center B-cell cases could be improved, the germinal center B-cell marker HGAL/GCET2 was also added to all three algorithms. Our results show that the inclusion of HGAL/GCET2 significantly increased the detection of germinal center B-cell cases in all three algorithms (P<0.001). The proportions of germinal center B-cell cases in the original algorithms were 27%, 34%, and 19% for Hans, Choi, and Tally, respectively. In the modified algorithms, with the inclusion of HGAL/GCET2, the frequencies of germinal center B-cell cases were increased to 38%, 48%, and 35%, respectively. Therefore, HGAL/GCET2 protein expression may function as a marker for germinal center B-cell type diffuse large B-cell lymphoma. Consideration should be given to the inclusion of HGAL/GCET2 analysis in algorithms to better predict the cell of origin. These findings bear further validation, from comparison to gene expression profiles and from clinical/therapeutic data.


Subject(s)
Algorithms , Biomarkers, Tumor/analysis , Immunohistochemistry , Lymphoma, Large B-Cell, Diffuse/chemistry , Neoplasm Proteins/analysis , Adolescent , Adult , Aged , Aged, 80 and over , Chi-Square Distribution , Child , Female , Humans , Intracellular Signaling Peptides and Proteins , Linear Models , Lymphoma, Large B-Cell, Diffuse/pathology , Male , Microfilament Proteins , Middle Aged , Predictive Value of Tests , Prognosis , Reproducibility of Results , Sensitivity and Specificity , Tissue Array Analysis , Young Adult
4.
Am J Surg Pathol ; 35(8): 1195-203, 2011 Aug.
Article in English | MEDLINE | ID: mdl-21716086

ABSTRACT

Extranodal natural killer/T-cell lymphoma, nasal type (NK/TCL) is more prevalent in Asia and in some areas of South and Central America, but it is rarely seen in the United States and Europe. In this study, a series of 122 cases of NK/TCL from Brazil was analyzed with respect to clinicopathologic features. Clinical characteristics and geographic distribution were evaluated in 97 cases of nasal/nasopharyngeal region and 23 cases in extranasal sites including 6 nodal cases. Clinical staging and follow-up information was available in a subset of 21 patients. All cases harbored Epstein-Barr virus (EBV), 95% and 85% expressed cytoplasmic CD3 and CD56, respectively, and all cases were positive for at least 1 marker for cytotoxic granules. The global distribution of EBV subtypes showed predominance of strain subtype A, 89%, and subtype B, 11%. No dual infections were detected. TCR-γ TCR-gene rearrangement was observed in 7 cases; all of them extranodal. Three of TCR-γ(+) cases showed EBV subtype A. Two TCR-γ(+)/CD56(+) cases showed EBV subtype B. Geographic distribution of NK/TCL showed higher frequency in the southeast and northeast regions of Brazil. Striking differences among geographic regions were seen with the vast majority of EBV subtype B (86%) occurring in the south and southeast regions.


Subject(s)
Herpesvirus 4, Human/classification , Lymphoma, Extranodal NK-T-Cell/virology , Lymphoma, T-Cell/virology , Adolescent , Adult , Aged , Aged, 80 and over , Brazil/epidemiology , Chi-Square Distribution , Child , DNA, Viral/isolation & purification , Female , Gene Rearrangement, gamma-Chain T-Cell Antigen Receptor , Genes, T-Cell Receptor gamma , Herpesvirus 4, Human/genetics , Humans , Immunohistochemistry , In Situ Hybridization , Kaplan-Meier Estimate , Lymph Nodes/pathology , Lymph Nodes/virology , Lymphoma, Extranodal NK-T-Cell/genetics , Lymphoma, Extranodal NK-T-Cell/mortality , Lymphoma, Extranodal NK-T-Cell/pathology , Lymphoma, T-Cell/genetics , Lymphoma, T-Cell/mortality , Lymphoma, T-Cell/pathology , Male , Middle Aged , Neoplasm Staging , Polymerase Chain Reaction , Prognosis , Residence Characteristics , Retrospective Studies , Survival Rate , Time Factors , Tissue Array Analysis , Young Adult
SELECTION OF CITATIONS
SEARCH DETAIL
...